Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2026-03-16 @ 5:28 PM
Study NCT ID:
NCT05386550
Status:
TERMINATED
Last Update Posted:
2025-06-13
First Post:
2022-05-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)
Sponsor:
Organization: